CLBCX
Price
$35.27
Change
-$0.35 (-0.98%)
Updated
Feb 21 closing price
Net Assets
244.57B
JDBRX
Price
$46.19
Change
-$0.49 (-1.05%)
Updated
Feb 21 closing price
Net Assets
26.62B
Ad is loading...

CLBCX vs JDBRX

Header iconCLBCX vs JDBRX Comparison
Open Charts CLBCX vs JDBRXBanner chart's image
American Funds American Balanced 529C
Price$35.27
Change-$0.35 (-0.98%)
VolumeN/A
Net Assets244.57B
Janus Henderson Balanced R
Price$46.19
Change-$0.49 (-1.05%)
VolumeN/A
Net Assets26.62B
CLBCX vs JDBRX Comparison Chart
Loading...
View a ticker or compare two or three
VS
CLBCX vs. JDBRX commentary
Feb 23, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CLBCX is a Buy and JDBRX is a StrongBuy.

Ad is loading...
FUNDAMENTALS
Fundamentals
CLBCX has more cash in the bank: 245B vs. JDBRX (26.6B). CLBCX pays higher dividends than JDBRX: CLBCX (1.52) vs JDBRX (1.36). CLBCX was incepted earlier than JDBRX: CLBCX (23 years) vs JDBRX (16 years). CLBCX is a more actively managed with annual turnover of: 171.00 vs. JDBRX (92.00). CLBCX has a lower initial minimum investment than JDBRX: CLBCX (250) vs JDBRX (2500). CLBCX annual gain was more profitable for investors over the last year : 8.39 vs. JDBRX (6.65). JDBRX return over 5 years is better than : 28.47 vs. CLBCX (26.92).
CLBCXJDBRXCLBCX / JDBRX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence23 years16 years-
Gain YTD2.7682.145129%
Front LoadN/AN/A-
Min. Initial Investment250250010%
Min. Initial Investment IRAN/AN/A-
Net Assets245B26.6B921%
Annual Yield % from dividends1.521.36112%
Returns for 1 year8.396.65126%
Returns for 3 years16.4414.26115%
Returns for 5 years26.9228.4795%
Returns for 10 years53.3765.2582%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
PFSI101.250.33
+0.33%
PennyMac Financial Services
ANTX1.13N/A
N/A
AN2 Therapeutics
DSGN4.91-0.10
-2.00%
Design Therapeutics
HAL26.26-0.73
-2.70%
Halliburton Company
INDI3.41-0.50
-12.79%
indie Semiconductor